|
Post by sayhey24 on Nov 26, 2018 19:32:34 GMT -5
Maybe its as simple as they have not had enough "collected and independently adjudicated major adverse cardiovascular events" in four years to do a study. It would not surprise me. Afrezza stops the post meal BG spike which is like a stake in the heart.
I would expect fewer cardiovascular events, flat as worse case, overall improved vascular health and flat to improved pulmonary function. What BP wants afrezza to show results like that? There is probably plenty of pressure on the FDA to cancel the whole damn thing. Afrezza study results when properly presented will always out-perform all other treatments.
|
|
|
Post by mango on Nov 27, 2018 14:28:14 GMT -5
Dear James, For any additional information regarding closed PMCs and PMRs, you must submit a Freedom of Information Act (FOI) request. I’ve provided the link below to the FDA web page where you will find a request form. www.fda.gov/regulatoryinformation/foi/default.htmRespectfully, Kathy Kathy Well Science Policy Analyst (PMRs/PMCs) CDER | OND | IO | SPRT Silver Spring, MD
|
|
|
Post by tomtabb on Nov 28, 2018 8:35:45 GMT -5
If the changes were significant, I would think MNKD would issue a press release to that effect, wouldn't they?
|
|
|
Post by mango on Nov 28, 2018 9:06:28 GMT -5
If the changes were significant, I would think MNKD would issue a press release to that effect, wouldn't they? I don't know, why don't you ask them?
|
|
|
Post by mango on Nov 28, 2018 9:39:29 GMT -5
Let's ask Mister Ed instead?
|
|
|
Post by factspls88 on Nov 29, 2018 9:23:26 GMT -5
Let's ask Mister Ed instead?
Of course!
|
|